Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-11-19 to 2024-12-09
Current total value of award: $1920.4
Description: 8511011143!HEPATITIS B VIRUS V